Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1987-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.31.8.1238PMID 3631945PMCID PMC174911
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthetic, Biochemical and Antiviral Aspects of Selected Acyclonucleosides and Their Derivatives.

  1986cited by this paper
• Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir

  1986influential reference
• Synthesis and antiherpetic activity of (S)-, (R)-, and (+/-)-9-[(2,3-dihydroxy-1-propoxy)methyl]guanine, linear isomers of 2'-nor-2'-deoxyguanosine.

  1985cited by this paper
• Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia.

  1985cited by this paper
• An improved synthesis of the antiviral acyclonucleoside 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine

  1985cited by this paper
• Comparison of the in vitro and in vivo antiherpes virus activities of the acyclic nucleosides, acyclovir (Zovirax) and 9-[(2-hydroxy-1-hydroxymethylethoxy)methyl]guanine (BWB759U).

  1985cited by this paper
• Intracellular metabolism and enzymatic phosphorylation of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and acyclovir in herpes simplex virus-infected and uninfected cells.

  1985cited by this paper
• Antiherpes Simplex Virus Activity of 9-[4-Hydroxy-3-(hydroxymethyl)-1-butyl] guanine

  1984influential reference
• 9-(3,4-dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplication

  1983cited by this paper
• 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.

  1983cited by this paper
• Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1.

  1983cited by this paper
• Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine

  1983cited by this paper
• Antiherpetic activity and mechanism of action of 9-(4-hydroxybutyl)guanine.

  1983cited by this paper
• Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro

  1983cited by this paper
• Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound, in herpes simplex virus-infected cells.

  1983cited by this paper
• A new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2

  1982cited by this paper
• Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication

  1980cited by this paper
• In vitro susceptibility of varicella-zoster virus to acyclovir

  1980cited by this paper
• Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus.

  1980cited by this paper
• Growth Inhibition by Acycloguanosine of Herpesviruses Isolated from Human Infections

  1979cited by this paper
• 9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group

  1978cited by this paper
• RELATIVE POTENCIES OF ANTI‐HERPES COMPOUNDS

  1977cited by this paper
• Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.

  1977cited by this paper
• A New Class of Nucleoside Analogues. Synthesis of N. -Pyrimidinyl-and N9-Purinyl-4′-hydrqxy-3-(Hydsoxymethyl)butanes1 # 2

  1972cited by this paper

• Antivirotics based on defective interfering particles: emerging concepts and challenges

  2025cites this paper
• Strategies and efforts in circumventing the emergence of antiviral resistance against conventional antivirals

  2025cites this paper
• Recent advance in management of herpes simplex in Japan

  2023cites this paper
• A Comparison Between Effects of Amenamevir and Famciclovir on Intensities of Acute Pain and the Incidence of Postherpetic Neuralgia in Adult Patients with Herpes Zoster

  2022cites this paper
• Benzothiazole Moiety and Its Derivatives as Antiviral Agents

  2021cites this paper
• The Oak Leaf: LSUA’s Journal of Undergraduate Teaching and Research

  2021cites this paper
• Advances and Perspectives in the Management of Varicella-Zoster Virus Infections

  2021cites this paper
• Evaluation of drug repositioning by molecular docking of pharmaceutical resources available in the Brazilian healthcare system against SARS-CoV-2

  2021cites this paper
• A review: Mechanism of action of antiviral drugs

  2021cites this paper
• DNA-RNA

  2021cites this paper
• An Updated Overview of Herpes Simplex Virus-1 Infection: Insights from Origin to Mitigation Measures

  2021cites this paper
• Modifications on the heterocyclic base of ganciclovir, penciclovir, acyclovir - syntheses and antiviral properties

  2020cites this paper
• Wavefunction analysis, charge transfer and molecular docking studies on famciclovir and entecavir: Potential anti-viral drugs

  2020cites this paper
• Solid-State Characterization and Compatibility Studies of Penciclovir, Lysine Hydrochloride, and Pharmaceutical Excipients

  2019cites this paper
• Herpesvirus Polymerase Inhibitors

  2019cites this paper
• Synthesis of 1,1,2-trisubstituted cyclopropane nucleosides in enantiomerically pure forms

  2019cites this paper
• Synthesis of Enantiomerically Pure 1,2,3-Trisubstituted Cyclopropane Nucleosides Using Pd-Catalyzed Substitution via Directing Group-Mediated C(sp3)-H Activation as a Key Step.

  2019cites this paper
• Engineering of Bioinspired, Size-Controllable, Self-Degradable Cancer-Targeting DNA Nanoflowers via the Incorporation of an Artificial Sandwich Base.

  2019cites this paper
• The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold

  2018cites this paper
• Synthesis of Purine‐based Triazoles by Copper (I)‐catalyzed Huisgen Azide–Alkyne Cycloaddition Reaction

  2018cites this paper
• Potential Therapeutic Agents for Feline Calicivirus Infection

  2018cites this paper
• Flexibility—Not just for yoga anymore!

  2018cites this paper
• Amino Acids in the Development of Prodrugs

  2018cites this paper
• Biophysical and In Silico Studies of the Interaction between the Anti-Viral Agents Acyclovir and Penciclovir, and Human Serum Albumin

  2017cites this paper
• Antiherpetic Drugs in Equine Medicine.

  2017cites this paper
• Efficacy of the early administration of valacyclovir hydrochloride for the treatment of neuropathogenic equine herpesvirus type-1 infection in horses.

  2017cites this paper
• 1'-Homonucleosides and their structural analogues: A review.

  2016cites this paper
• A review of antiviral drugs and other compounds with activity against feline herpesvirus type 1.

  2016cites this paper
• In vitro Anti-Herpes simplex Type-1 Virus Evaluation of Extracts from Kenya Grown Pyrethrum (Chrysanthemum cinerariaefolium)

  2016cites this paper
• Efficacy of antiviral drug combinations against equine herpes virus type 1 in vitro

  2015cites this paper
• Tenofovir: Structure-Activity Relationship and Synthetic Methods

  2015cites this paper
• When biologist meets chemist: a search for HIV-1 inhibitors

  2015cites this paper
• Current prodrug strategies for improving oral absorption of nucleoside analogues

  2014cites this paper
• One‐year follow‐up of zoster‐associated pain in 764 immunocompetent patients with acute herpes zoster treated with famciclovir (FAMILIAR study)

  2014cites this paper
• Human herpes simplex virus: Life cycle and development of inhibitors

  2014cites this paper
• Diversity oriented efficient access of trisubstituted purines via sequential regioselective Mitsunobu coupling and SNAr based C6 functionalizations

  2013cites this paper
• SEARCH OF INHIBITORS OF HERPES VIRAL REPLICATION: 30 YEARS AFTER ACYCLOVIR

  2013cites this paper
• Advances in the treatment of varicella-zoster virus infections.

  2013cites this paper
• Guanine‐Based Nucleoside Analogs as Antiviral Agents

  2013cites this paper
• Associated with the Epstein-Barr Virus

  2012cites this paper
• Vaccines and Antiviral Drugs for Diseases Associated with the Epstein-Barr Virus

  2012cites this paper
• DETERMINATION OF PENCYCLOVIR IN HUMAN PLASMA

  2012cites this paper
• 5-azacytosine compounds in medicinal chemistry: current stage and future perspectives.

  2012cites this paper
• Famciclovir

  2012cites this paper
• Synthesis and antiviral activity of benzimidazolyl- and triazolyl-1,3,5-triazines

  2012cites this paper
• Increasing Lipophilicity for Oral Drug Delivery

  2011cites this paper
• C-6 pyrimidine analogs for the PET imaging of HSV1-thymidine kinase expression

  2011cites this paper
• Determination of penciclovir in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a clinical pharmacokinetic study.

  2011cites this paper
• Emerging drugs for varicella-zoster virus infections

  2011cites this paper
• Synthesis of Novel 6-Azapyrimidine Acyclic Nucleoside Analogues and Antiviral Evaluation

  2010cites this paper
• The Resurgence of Acyclic Nucleic Acids

  2010cites this paper
• Radiolabeled nucleoside analogues for PET imaging of HSV1-tk gene expression.

  2010cites this paper
• Anti‐DNA Virus Agents

  2010cites this paper
• Antiviral therapy in patients with hematologic malignancies, transplantation, and aplastic anemia.

  2009cites this paper
• 9-[4-Hydroxy-3-(hydroxymethyl)butyl]guanine monohydrate

  2009cites this paper
• In vivo quantification of acyclovir exposure in the dermis following iontophoresis of semisolid formulations.

  2009cites this paper
• Viral DNA Polymerase Inhibitors

  2009cites this paper
• Antiviral Chemistry & Chemotherapy's Current Antiviral Agents FactFile (2nd Edition): DNA Viruses

  2008cites this paper
• New advances in anti-HSV chemotherapy.

  2008cites this paper
• Herpes simplex virus: Drug resistance and new treatment options using natural products (Review).

  2008cites this paper
• Clinical efficacy of prophylactic strategy of long‐term low‐dose acyclovir for Varicella‐Zoster virus infection after allogeneic peripheral blood stem cell transplantation *

  2008cites this paper
• Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting.

  2008cites this paper
• HPLC method for the determination of penciclovir in human plasma and application to a bioequivalence study.

  2008cites this paper
• Antiviral Chemistry & Chemotherapy's Current Antiviral Agents FactFile (2nd Edition): Retroviruses and Hepadnaviruses

  2008cites this paper
• Single-day treatment for orolabial and genital herpes: a brief review of pathogenesis and pharmacology

  2008influential citation
• In vitro susceptibility

  2007cites this paper
• What is after cytokine-blocking therapy, a novel therapeutic target--synovial Epstein-Barr virus for rheumatoid arthritis.

  2007cites this paper
• Development and validation of a high-performance liquid chromatography-tandem mass spectrometry for the determination of penciclovir in human plasma: application to a bioequivalence study.

  2007cites this paper
• In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet.

  2007cites this paper
• Case Study: Famciclovir: A Prodrug of Penciclovir

  2007cites this paper
• Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up.

  2007cites this paper
• Antiviral Chemistry & Chemotherapy's Current Antiviral Agents FactFile 2006 (1st edition): The RNA Viruses with DNA Intermediates (Retroviruses)

  2006cites this paper
• Antiviral prodrugs – the development of successful prodrug strategies for antiviral chemotherapy

  2006cites this paper
• Activity and Mechanism of Action of N-Methanocarbathymidine against Herpesvirus and Orthopoxvirus Infections

  2006cites this paper
• New antiviral agents

  2006cites this paper
• Famciclovir for the treatment of recurrent genital herpes: a clinical and pharmacological perspective

  2006cites this paper
• Development and validation of a new reversed-phase ion pairing liquid chromatographic method with fluorescence detection for penciclovir analysis in plasma and aqueous humor.

  2005cites this paper
• Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trial.

  2005cites this paper
• The tolerance to and pharmacokinetics of penciclovir (BRL 39123A), a novel antiherpes agent, administered by intravenous infusion to healthy subjects

  2005cites this paper
• Reinfection and reactivation of equine herpesvirus-1 in the mouse

  2005cites this paper
• Famciclovir for the Management of Genital Herpes Simplex in Patients with Inadequate Response to Aciclovir or Valaciclovir

  2005cites this paper
• In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?

  2004cites this paper
• 5-(1-Substituted) alkyl pyrimidine nucleosides as antiviral (herpes) agents.

  2004cites this paper
• Characterisation of penciclovir resistant acyclovir sensitive herpes simplex virus type 2 isolated from an AIDS patient

  2004cites this paper
• Lack of a pharmacokinetic interaction between oral famciclovir and allopurinol in healthy volunteers

  2004cites this paper
• Review of antiviral therapy for herpes labialis, genital herpes and herpes zoster

  2003cites this paper
• cycloSal-Pronucleotides—Design of the Concept, Chemistry, and Antiviral Activity

  2003cites this paper
• The thymidine kinase of Epstein-Barr virus and herpes simplex virus and their application as suicide genes

  2003influential citation
• Current and potential therapies for the treatment of herpes-virus infections.

  2003cites this paper
• Analysis of numbers of repeated units in R2 region among varicella-zoster virus strains.

  2003cites this paper
• Enhanced production of fattiviracins by bacitracin-resistant strains of Streptomyces microflavus strain No. 2445.

  2003cites this paper
• Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials

  2003cites this paper
• Herpes Simplex Virus Resistance to Acyclovir and Penciclovir after Two Decades of Antiviral Therapy

  2003cites this paper
• Fattiviracins, Antiviral Antibiotics Produced by an Actinomycete

  2003cites this paper
• Antiviral agents: Nonantiviral drugs

  2002cites this paper
• Comparison of methods for identifying resistant herpes simplex virus and measuring antiviral susceptibility.

  2002cites this paper
• Susceptibilities of Herpes Simplex Viruses to Penciclovir and Acyclovir in Eight Cell Lines

  2002cites this paper
• Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial

  2002cites this paper
• Antiviral agents: Non-antiretroviral [correction of Nonantiviral] drugs.

  2002cites this paper
• Chapter 9 – Viral Hepatitis

  2002cites this paper